Susquehanna International Group’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Sell
47,886
-236,211
-83% -$1.43M ﹤0.01% 10974
2025
Q4
$1.49M Buy
284,097
+36,350
+15% +$144K ﹤0.01% 6274
2025
Q3
$1.07M Buy
247,747
+129,519
+110% +$233K ﹤0.01% 7198
2025
Q2
$124K Buy
118,228
+53,186
+82% +$63.6K ﹤0.01% 11650
2025
Q1
$83.9K Buy
65,042
+40,476
+165% +$63.8K ﹤0.01% 11648
2024
Q4
$61.4K Sell
24,566
-33,292
-58% -$119K ﹤0.01% 11594
2024
Q3
$235K Buy
+57,858
New +$216K ﹤0.01% 10134
2024
Q1
Sell
-12,037
Closed -$56.2K 13534
2023
Q4
$56.2K Buy
+12,037
New +$60.2K ﹤0.01% 11670

Other funds holding ZURA

Susquehanna International Group's ZURA Position: Q1 2026 in Review

Susquehanna International Group reduced its Zura Bio (ZURA) stake by 83% in Q1 2026, selling an estimated $1.43M and leaving 47,886 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #10974.

Susquehanna International Group first reported a position in ZURA in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.49M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Susquehanna International Group held 47,886 shares of Zura Bio worth $285K as of Q1 2026.
  • Susquehanna International Group sold 236,211 Zura Bio shares in Q1 2026, an estimated $1.43M.
  • Zura Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10974 holding.
  • Susquehanna International Group first reported a position in Zura Bio in Q4 2023 and has held it in 8 quarters since.
  • Susquehanna International Group's Zura Bio position peaked at $1.49M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.